Magali Gary-Bobo Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

2/2009	Adiponectin normalization: a clue to the anti-metabolic syndrome action of rimonabant.
7/2007	Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magali Gary-Bobo Research Topics

Disease

46	Neoplasms (Cancer) 05/2024 - 11/2011
30	Breast Neoplasms (Breast Cancer) 05/2021 - 03/2009
4	Prostatic Neoplasms (Prostate Cancer) 07/2023 - 05/2015
3	Phototoxic Dermatitis (Phototoxicity) 09/2019 - 12/2010
3	Glycogen Storage Disease Type II (Pompe's Disease) 01/2019 - 11/2016
3	Obesity 02/2009 - 02/2006
2	Adenocarcinoma 11/2022 - 12/2021
2	Neoplasm Metastasis (Metastasis) 05/2021 - 11/2012
2	Inflammation (Inflammations) 09/2017 - 07/2007
2	Type 2 Diabetes Mellitus (MODY) 02/2016 - 02/2006
2	Colorectal Neoplasms (Colorectal Cancer) 09/2012 - 02/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2009 - 07/2007
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Rhabdomyosarcoma 07/2020
1	Colonic Neoplasms (Colon Cancer) 03/2020
1	Muscular Diseases (Myopathy) 11/2016
1	Diabetes Mellitus 02/2016

Drug/Important Bio-Agent (IBA)

16	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2022 - 03/2009
12	Mannose (D-Mannose)IBA 07/2020 - 03/2009
8	Silicon Dioxide (Silica)FDA LinkGeneric 06/2019 - 11/2011
7	PorphyrinsIBA 05/2022 - 05/2013
6	Small Interfering RNA (siRNA)IBA 10/2023 - 09/2015
6	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 05/2015
5	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2012
5	LigandsIBA 12/2023 - 02/2016
5	SiliconIBA 10/2023 - 05/2013
4	Photosensitizing Agents (Photosensitizers)IBA 07/2023 - 02/2012
4	EnzymesIBA 01/2019 - 07/2007
3	GoldIBA 09/2019 - 01/2015
3	Cathepsin DIBA 01/2019 - 12/2012
3	GlucosidasesIBA 10/2018 - 02/2016
3	CamptothecinIBA 12/2013 - 02/2012
3	AdiponectinIBA 02/2009 - 02/2006
3	RimonabantIBA 02/2009 - 02/2006
2	AntigensIBA 05/2024 - 01/2024
2	Monoclonal AntibodiesIBA 05/2024 - 01/2024
2	Singlet OxygenIBA 07/2023 - 07/2021
2	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 01/2023 - 04/2021
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2022 - 02/2016
2	Mannose ReceptorIBA 11/2022 - 12/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 07/2020
2	LuciferasesIBA 07/2020 - 09/2019
2	AT 760IBA 09/2019 - 09/2016
2	CationsIBA 06/2019 - 05/2015
2	pepstatin (pepstatin A)IBA 01/2019 - 10/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 12/2012
2	AcidsIBA 10/2018 - 11/2016
2	Estrogen Receptor Modulators (Antiestrogen)IBA 08/2016 - 11/2012
2	Proteasome InhibitorsIBA 08/2016 - 11/2012
2	Bortezomib (Velcade)FDA Link 08/2016 - 11/2012
2	Estrogen ReceptorsIBA 08/2016 - 11/2012
2	Volatile Oils (Essential Oils)IBA 04/2014 - 02/2014
2	Estrogen Receptor alphaIBA 11/2012 - 11/2012
2	AdipokinesIBA 02/2009 - 02/2006
1	ZincIBA 02/2024
1	SilanesIBA 02/2024
1	sulfobetaineIBA 02/2024
1	Dihydrotachysterol (AT 10)IBA 02/2024
1	diazonaphthalenedisulfonic acid (NDS)IBA 12/2022
1	Polymethyl Methacrylate (Sol)IBA 12/2022
1	ethyleneIBA 12/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 07/2021
1	Chemokine ReceptorsIBA 05/2021
1	ChemokinesIBA 05/2021
1	TinIBA 04/2021
1	Contrast MediaIBA 12/2020
1	PolymersIBA 07/2020
1	MicellesIBA 03/2020
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2020
1	EthaneIBA 11/2019
1	DiaminesIBA 09/2019
1	malonic acid (malonate)IBA 09/2019
1	PlatinumIBA 09/2019
1	Dendrimers (Dendrons)IBA 03/2019
1	Peptides (Polypeptides)IBA 01/2019
1	LipopolysaccharidesIBA 09/2017
1	Diclofenac (SR 38)FDA LinkGeneric 09/2017
1	Hydroxyl RadicalIBA 08/2016
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 08/2016
1	Tamoxifen FDA LinkGeneric 08/2016
1	Fulvestrant (Faslodex)FDA Link 08/2016
1	AzidesIBA 07/2016
1	CopperIBA 07/2016
1	Alkynes (Acetylenes)IBA 07/2016
1	mannose-6-phosphateIBA 06/2016
1	Acarbose FDA LinkGeneric 02/2016
1	Synthetic DrugsIBA 02/2016
1	RutheniumIBA 02/2016
1	DisulfidesIBA 08/2015
1	rhodamine BIBA 07/2015
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 05/2015

Therapy/Procedure

17	Therapeutics 05/2024 - 02/2012
17	Photochemotherapy (Photodynamic Therapy) 01/2023 - 11/2011
7	Precision Medicine 12/2022 - 05/2015
4	Lasers (Laser) 12/2021 - 09/2016
3	Drug Therapy (Chemotherapy) 07/2023 - 03/2020
1	Enzyme Therapy 01/2019
1	Enzyme Replacement Therapy 10/2018
1	Nanospheres 01/2016